Seminars in fetal & neonatal medicineHumansAntifungal AgentsInfantNewbornFluconazole
Antifungal prophylaxis-Where are we today?
David A Kaufman
Published: 202510.1016/j.siny.2025.101682
Abstract
In the past decades more infants of lower gestational ages (GAs) have developed invasive Candida infection (ICI) from nonmodifiable risk factors of immature immunity and underdeveloped immune barriers (skin, gastrointestinal and respiratory tracts).…
Preview only. Read the full abstract at the source